Literature DB >> 9747840

A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer.

A Tinger1, J M Michalski, A Cheng, D A Low, R Zhu, W R Bosch, J A Purdy, C A Perez.   

Abstract

PURPOSE: To determine an adequate planning target volume (PTV) margin for three-dimensional conformal radiotherapy (3D CRT) of prostate cancer, the uncertainties in the internal positions of the prostate and seminal vesicles (SV) and in the treatment setups were measured. METHODS AND MATERIALS: Weekly computed tomography (CT) scans of the pelvis (n=51) and daily electronic portal images (n=1630) were reviewed for eight patients who received seven-field 3D CRT for prostate cancer. The CT scans were registered in three dimensions to the original planning CT scan using commercially available software to measure the center-of volume (COV) motion of the prostate and SV. The daily portal images were registered to the corresponding simulation films to measure the setup displacements. The standard deviation (SD) of the internal organ motions was added to the SD of the setups in quadrature to determine the total uncertainty. Positive directions were left, anterior, and superior. Rotations necessary to register the CT scans and portal images were minimal and not further analyzed.
RESULTS: The mean motion for the COV of the prostate+/-the SD was 0+/-0.9 mm in the left-right (LR), 0.5+/-2.6 mm in the anterior-posterior (AP), and 1.5+/-3.9 mm in the superior-inferior (SI) directions. The mean motion for the COV of the SV+/-the SD was 0.3+/-1.7 mm in the LR, 0.7+/-3.8 mm in the AP, and 0.9+/-3.5 mm in the SI directions. For all patients the mean isocenter displacement+/-the SD was 0+/-3.1 mm in the LR, 1.4+/-3.0 mm in the AP, and -0.4+/-2.1 mm in the SI directions. The total uncertainty for the prostate was 3.2 mm, 4.0 mm, and 4.4 mm in the LR, AP, and SI directions, respectively. For the SV, the total uncertainty was 3.5, 4.8, and 4.1 mm in the LR, AP, and SI directions, respectively.
CONCLUSIONS: PTV margins of 10 to 16 mm are required to encompass all (99%) possible positions of the prostate or SV during 3D CRT. PTV margins of 7 to 11 mm will encompass the measured uncertainties with a 95% probability. PTV margins of 5 mm may not adequately cover the intended volume.

Entities:  

Mesh:

Year:  1998        PMID: 9747840     DOI: 10.1016/s0360-3016(98)00189-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  A novel correction factor based on extended volume to complement the conformity index.

Authors:  F Jin; Y Wang; Y-Z Wu
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

Review 2.  Adaptive radiation therapy for prostate cancer.

Authors:  Michel Ghilezan; Di Yan; Alvaro Martinez
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

3.  Advances in prostate cancer treatment: highlights from the 2nd international prostate cancer congress, st. Thomas, u.s. Virgin islands, july 17-20, 2002.

Authors:  Matthew B Gretzer; Alan W Partin
Journal:  Rev Urol       Date:  2003

4.  Quantifying the dosimetric impact of organ-at-risk delineation variability in head and neck radiation therapy in the context of patient setup uncertainty.

Authors:  Eric Aliotta; Hamidreza Nourzadeh; Jeffrey Siebers
Journal:  Phys Med Biol       Date:  2019-07-05       Impact factor: 3.609

5.  Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers.

Authors:  David Skarsgard; Pat Cadman; Ali El-Gayed; Robert Pearcey; Patricia Tai; Nadeem Pervez; Jackson Wu
Journal:  Radiat Oncol       Date:  2010-06-10       Impact factor: 3.481

6.  Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.

Authors:  D P Dearnaley; E Hall; D Lawrence; R A Huddart; R Eeles; C M Nutting; J Gadd; A Warrington; M Bidmead; A Horwich
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

7.  Random variation in rectal position during radiotherapy for prostate cancer is two to three times greater than that predicted from prostate motion.

Authors:  J Scaife; K Harrison; M Romanchikova; A Parker; M Sutcliffe; S Bond; S Thomas; S Freeman; R Jena; A Bates; N Burnet
Journal:  Br J Radiol       Date:  2014-08-20       Impact factor: 3.039

8.  Strategies to evaluate the impact of rectal volume on prostate motion during three-dimensional conformal radiotherapy for prostate cancer.

Authors:  Ana Paula Diniz Fortuna Poli; Rodrigo Souza Dias; Adelmo José Giordani; Helena Regina Comodo Segreto; Roberto Araujo Segreto
Journal:  Radiol Bras       Date:  2016 Jan-Feb

9.  Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.

Authors:  Mohamed Metwaly; Awaad Mousa Awaad; El-Sayed Mahmoud El-Sayed; Abdel Sattar Mohamed Sallam
Journal:  J Appl Clin Med Phys       Date:  2008-10-24       Impact factor: 2.102

10.  Development of a treatment planning protocol for prostate treatments using intensity modulated radiotherapy.

Authors:  G A Ezzell; S E Schild; W W Wong
Journal:  J Appl Clin Med Phys       Date:  2001       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.